Obstructive Lung Diseases Withdrawn Phase 2 Trials for PF-00610355 (DB11871)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00830427A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsTreatment